Compare Neurocrine Biosciences Inc (NBIX) vs Workiva Inc (WK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Workiva Inc — how do they compare? Neurocrine Biosciences Inc trades at $158.59 (market cap $16.46B), while Workiva Inc trades at $68.8 (market cap $3.76B). The key difference: Neurocrine Biosciences Inc is far larger — about 4.4× Workiva Inc's market cap. Which is the better fit depends on your goals.
| NBIX | WK | |
|---|---|---|
Market Cap | $16.46B | $3.76B |
Sector | Health | Technology |
52-Week High | $185.50 | $93.31 |
52-Week Low | $123.10 | $44.31 |
Enterprise Value | $16.48B | $3.73B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Workiva Inc
Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →
